Abbott out-licenses asthma agent
Executive Summary
Abbott licenses rights for controlled-release and I.V. formulations of asthma agent zileuton to Critical Therapeutics. Abbott markets an immediate-release version of zileuton, Zyflo Filmtab. Critical Therapeutics will handle all regulatory, manufacturing and marketing responsibility and will make milestone and royalty payments to Abbott...